The role of epithelial-mesenchymal transition in regulating radioresistance

Crit Rev Oncol Hematol. 2020 Jun:150:102961. doi: 10.1016/j.critrevonc.2020.102961. Epub 2020 Apr 16.

Abstract

Cancer patients with different stages can benefit from radiotherapy, but there are still limited due to inherent or acquired radioresistance. The epithelial-mesenchymal transition (EMT) is a complex biological process that is implicated in malignant characteristics of cancer, such as radioresistance. Although the possible mechanisms of EMT-dependent radioresistance are being extensively studied, there is a lack of a clear picture of the overall signaling of EMT-mediated radioresistance. In this review, we highlight the role and possible molecular mechanisms of EMT in cancer radioresistance, in particular to EMT-associated signaling pathway, EMT-inducing transcription factors (EMT-TFs), EMT-related non-coding RNAs. The knowledge of EMT-associated mechanisms of radioresistance will offer more potent therapy targets to improve the radiotherapy responses.

Keywords: EMT; Mechanism; Non-coding RNAs; Radioresistance; Signaling pathway.

Publication types

  • Review

MeSH terms

  • Epithelial-Mesenchymal Transition / physiology*
  • Humans
  • Neoplasms / pathology*
  • Radiation Tolerance*
  • Signal Transduction
  • Transcription Factors

Substances

  • Transcription Factors